Vitazi.ai, Inc. is a software development company headquartered in San Diego, California, with a small team size. The company specializes in retinal health intelligence solutions using advanced software applications.
Subscribe to see Vitazi.AI, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vitazi.AI, Inc. is a diagnostic imaging company headquartered in Santa Fe, United States. It has raised at least $3.5M across the 4 funding rounds on record, 3 of them with a disclosed amount. Its most recent funding round raised $500,000 in December 2025. Xcout tracks 6 named people at Vitazi.AI, Inc., including Jeremy Stueven (President & CEO).
As of 16 November 2026. Source: Xcout Intel.
At least $3.5M raised across the 4 rounds on record (3 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $500,000 | — | |
| SEC Form D filing | $1.2M | — | |
| SEC Form D filing | $1.7M | — | |
| Venture | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Vitazi.AI, Inc.'s closest competitors — see the full list of competitors and alternatives →
Founded in 2017 and headquartered in Houston, United States, RETINA-AI Health, Inc. specializes in creating artificial intelligence-driven solutions for diabetic retinopathy detection and patient health monitoring.
Altris AI is a software and artificial intelligence company focused on decision support and risk analysis tools for eye care.
RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
CIPRA.ai is a digital health company headquartered in San Diego, California. The company leverages artificial intelligence to deliver personalized health recommendations and management tools for conditions such as hypertension and diabetes.
NeuroVision Imaging, Inc. is a healthcare technology company headquartered in Sacramento, California. Founded in 2010, the company develops digital imaging and diagnostic solutions to identify retinal biomarkers and neurological conditions.
Retinex, Inc. develops an AI-native electronic medical record (EMR) software platform designed for healthcare providers. The cloud-based, ONC-certified system features native HL7 FHIR architecture, ambient clinical intelligence for documentation, and interoperable data exchange to streamline clinical workflows.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Vitazi.AI, Inc.? Suggest a correction · Work at Vitazi.AI, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.